Description

Description

Paraxyl CR 12.5mg Tablet is a controlled-release antidepressant medicine belonging to the selective serotonin reuptake inhibitor (SSRI) class of drugs, prescribed for adults dealing with major depressive disorder and certain anxiety-related conditions. Unlike the standard immediate-release formulation, this tablet is designed to release its active ingredient gradually over an extended period, which is intended to provide a steadier level of medicine in the bloodstream and may help reduce the intensity of certain side effects, particularly nausea, that some patients experience when starting treatment. The 12.5mg strength is generally used as a starting dose, allowing the body to adjust gradually before a doctor considers whether an increase is needed based on individual response. The pack contains 30 tablets, typically supporting a full month of treatment based on a once-daily dosing schedule. Because this medicine works gradually on brain chemistry and relies on its controlled-release design, it should always be taken consistently and only under continued medical supervision.

Ingredients

The active ingredient in Paraxyl CR 12.5mg Tablet is Paroxetine, formulated in a controlled-release matrix and present at a strength equivalent to 12.5mg per tablet. This compound works by selectively blocking the reuptake of serotonin in the brain, allowing more of this chemical messenger to remain available between nerve cells to support gradual mood stabilization. The controlled-release design relies on excipients such as hypromellose, which forms the matrix controlling the medicine’s slow release, along with microcrystalline cellulose, magnesium stearate, and a film-coating layer that protects the tablet and supports its extended-release mechanism.

Dosage Form

Paraxyl CR is manufactured as a controlled-release, film-coated oral tablet, engineered with a specialized release matrix that allows the medicine to be absorbed gradually over several hours rather than all at once. The tablets are packed in blister strips designed to protect them from moisture and light, helping preserve the release mechanism’s integrity until the expiry date printed on the packaging.

Uses

Paraxyl CR 12.5mg Tablet is used in the treatment of major depressive disorder, helping to gradually improve low mood, restore interest in daily activities, and reduce feelings of hopelessness over the course of treatment. It is also prescribed for certain anxiety-related conditions, including panic disorder, social anxiety disorder, and generalized anxiety disorder, depending on individual diagnosis and clinical judgment. The controlled-release design of this tablet is often chosen for patients who are more sensitive to the digestive side effects associated with immediate-release Paroxetine, or for those beginning treatment for the first time who may benefit from a gentler introduction to the medicine. As with other antidepressants in this class, noticeable improvement typically takes several weeks of consistent use, and treatment is generally combined with counseling, therapy, or other supportive measures as guided by a mental health professional.

How to Use

Paraxyl CR 12.5mg Tablet should be taken exactly as prescribed by the doctor, generally once daily, often in the morning with food to further help minimize digestive discomfort. The tablet must always be swallowed whole with a glass of water and should never be crushed, split, or chewed, as doing so would disrupt the controlled-release matrix and cause the medicine to be released too quickly, potentially increasing the risk of side effects. Patients are usually started at this 12.5mg dose, and the doctor may consider a gradual increase based on individual response and tolerability over subsequent weeks. This medicine should be continued for the full duration recommended by the doctor, even after symptoms begin to improve, and should never be stopped suddenly without medical guidance, as doing so may lead to withdrawal-like symptoms; a doctor will typically recommend a gradual dose reduction when discontinuing treatment. If a dose is missed, it should be taken as soon as remembered, unless the next dose is nearly due, in which case the missed dose should be skipped rather than doubled.

Side Effects

Paraxyl CR 12.5mg Tablet may cause side effects, though the controlled-release design is generally associated with a somewhat gentler digestive tolerability profile compared to immediate-release Paroxetine. Commonly reported effects include nausea, dry mouth, drowsiness or altered sleep patterns, dizziness, sweating, and changes in appetite. Sexual side effects, such as reduced libido or difficulty reaching orgasm, are also fairly common with this class of medicine. Some patients may experience restlessness or agitation, particularly during the early weeks of treatment. In rare but serious cases, this medicine has been associated with an increased risk of suicidal thoughts or behavior, particularly in children, adolescents, and young adults, especially during the initial weeks of treatment or following a dose adjustment; close monitoring during this period is important, and any worsening mood or thoughts of self-harm should be reported to a doctor immediately. Discontinuation symptoms such as dizziness, irritability, or flu-like sensations may also occur if the medicine is stopped abruptly.

Pregnancy & Breastfeeding

The use of Paraxyl CR 12.5mg Tablet during pregnancy requires careful discussion with a doctor, as Paroxetine has been associated with a potential increased risk of certain birth-related concerns when taken during early pregnancy, and with possible short-term complications in newborns when taken later in pregnancy. Women who are pregnant, planning a pregnancy, or breastfeeding should inform their doctor before starting or continuing this medicine so that the risks and benefits can be carefully weighed. This medicine should never be stopped abruptly during pregnancy without medical guidance, as untreated depression or anxiety can also carry risks, and any changes to treatment should be made under close medical supervision.

Storage Instructions

Store Paraxyl CR 12.5mg Tablets in a cool, dry place away from direct sunlight, excess heat, and moisture, ideally at a temperature below 30°C. Keep the tablets in their original blister packaging until they are ready to be used, to help protect the controlled-release coating, and store them securely out of the reach and sight of children and pets. Avoid storing this medicine in bathrooms or other humid areas, and never allow the tablets to freeze. Always check the expiry date before use, and dispose of any expired or unused tablets responsibly through a proper medicine disposal program rather than household waste or drains.

FAQS

Q1. What does “CR” mean in Paraxyl CR?
CR stands for controlled-release, meaning the medicine is released gradually over time rather than all at once, which is generally associated with a gentler digestive tolerability profile.

Q2. Can this tablet be crushed or split if swallowing whole is difficult?
No, it should always be swallowed whole, as crushing or splitting can disrupt the controlled-release matrix and cause the medicine to be absorbed too quickly.

Q3. Why is the starting dose lower for the CR formulation?
The 12.5mg starting dose allows the body to gradually adjust to the medicine, particularly helpful for patients beginning antidepressant treatment for the first time.

Q4. How does this compare to the standard Paraxyl tablet in terms of side effects?
Many patients experience somewhat better digestive tolerability with the controlled-release formulation compared to the immediate-release tablet, though individual responses can vary.

Q5. How long should this medicine be continued once symptoms improve?
Treatment duration should always be guided by a doctor, as stopping too early, even after symptoms improve, may increase the likelihood of the condition returning.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.